Norges Bank’s Integra LifeSciences IART Stock Holding History

Norges Bank’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-395,385	Closed	-$8.97M	–	1792
2024 Q4	$8.97M	Buy	395,385 +350,063	+772%	+$7.64M	﹤0.01%	1375
2024 Q3	$824K	Sell	45,322 -641,512	-93%	-$14.9M	﹤0.01%	1749
2024 Q2	$20M	Buy	686,834 +28,893	+4%	+$857K	﹤0.01%	1219
2024 Q1	$23.3M	Sell	657,941 -14,200	-2%	-$568K	﹤0.01%	1219
2023 Q4	$29.3M	Buy	672,141 +36,245	+6%	+$1.43M	0.01%	1148
2023 Q3	$24.3M	Hold	635,896	–	–	﹤0.01%	1154
2023 Q2	$26.2M	Hold	635,896	–	–	0.01%	1135
2023 Q1	$36.5M	Sell	635,896 -75,222	-11%	-$4.24M	0.01%	990
2022 Q4	$39.9M	Buy	711,118 +59,576	+9%	+$3.03M	0.01%	902
2022 Q3	$27.6M	Buy	651,542 +29,797	+5%	+$1.53M	0.01%	1058
2022 Q2	$33.6M	Sell	621,745 -32,901	-5%	-$1.98M	0.01%	978
2022 Q1	$42.1M	Sell	654,646 -21,608	-3%	-$1.42M	0.01%	981
2021 Q4	$45.3M	Buy	676,254 +219,198	+48%	+$14.8M	0.01%	993
2021 Q3	$31.3M	Sell	457,056 -243,525	-35%	-$17.2M	0.01%	1182
2021 Q2	$47.8M	Sell	700,581 -4,531	-0.6%	-$320K	0.01%	999
2021 Q1	$48.7M	Sell	705,112 -8,118	-1%	-$550K	0.01%	989
2020 Q4	$46.3M	Buy	713,230 +84,817	+13%	+$4.56M	0.01%	1032
2020 Q3	$29.7M	Sell	628,413 -115,273	-16%	-$5.48M	0.01%	1169
2020 Q2	$34.9M	Buy	743,686 +9,195	+1%	+$452K	0.01%	1085
2020 Q1	$32.8M	Buy	734,491 +10,360	+1%	+$544K	0.01%	931
2019 Q4	$42.2M	Hold	724,131	–	–	0.01%	1032
2019 Q3	$43.5M	Buy	724,131 +8,089	+1%	+$482K	0.01%	951
2019 Q2	$40M	Sell	716,042 -19,894	-3%	-$1.02M	0.01%	1015
2019 Q1	$41M	Buy	735,936 +23,272	+3%	+$1.19M	0.01%	994
2018 Q4	$32.1M	Hold	712,664	–	–	0.01%	1072
2018 Q3	$46.9M	Hold	712,664	–	–	0.02%	916
2018 Q2	$45.9M	Buy	712,664 +156,230	+28%	+$9.67M	0.02%	896
2018 Q1	$30.8M	Buy	556,434 +29,865	+6%	+$1.57M	0.01%	1128
2017 Q4	$25.2M	Sell	526,569 -4,347	-0.8%	-$213K	0.01%	1318
2017 Q3	$26.8M	Buy	530,916 +46,675	+10%	+$2.4M	0.01%	1251
2017 Q2	$26.4M	Buy	484,241 +88,518	+22%	+$4.23M	0.01%	1199
2017 Q1	$16.7M	Sell	395,723 -344,965	-47%	-$14.7M	0.01%	1503
2016 Q4	$31.8M	Sell	740,688 -283,212	-28%	-$11.5M	0.01%	967
2016 Q3	$40.4M	Buy	1,023,900 +20,000	+2%	+$838K	0.02%	747
2016 Q2	$40M	Sell	1,003,900 -105,014	-9%	-$3.78M	0.02%	755
2016 Q1	$37.3M	Hold	1,108,914	–	–	0.02%	767
2015 Q4	$37.6M	Buy	1,108,914 +344,160	+45%	+$10.8M	0.02%	758
2015 Q3	$22.8M	Sell	764,754 -11,211	-1%	-$351K	0.01%	1048
2015 Q2	$21.4M	Hold	775,965	–	–	0.01%	1160
2015 Q1	$19.6M	Buy	775,965 +77,798	+11%	+$1.84M	0.01%	1222
2014 Q4	$15.5M	Buy	698,167 +205,651	+42%	+$4.17M	0.01%	1375
2014 Q3	$9.99M	Sell	492,516 -492,517	-50%	-$9.8M	0.01%	1603
2014 Q2	$18.9M	Buy	985,033 +492,517	+100%	+$9.18M	0.01%	1649
2014 Q1	$9.26M	Hold	492,516	–	–	0.01%	1611
2013 Q4	$9.61M	Hold	492,516	–	–	0.01%	1591
2013 Q3	$8.1M	Buy	492,516 +128,442	+35%	+$2.06M	﹤0.01%	1681
2013 Q2	$5.45M	Buy	+364,074	New	+$5.34M	﹤0.01%	1802

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank's IART Position: Q1 2025 in Review

Norges Bank sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 395,385 shares — an estimated $8.97M sold.

Norges Bank first reported a position in IART in Q2 2013 and held it in 47 quarters. The position peaked at $48.7M in Q1 2021. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

Norges Bank reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
Norges Bank sold 395,385 Integra LifeSciences shares in Q1 2025, an estimated $8.97M.
Norges Bank first reported a position in Integra LifeSciences in Q2 2013 and held it in 47 quarters.
Norges Bank's Integra LifeSciences position peaked at $48.7M in Q1 2021.
219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.